NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/06/2026
Back to search
Official data from USPTO
ETHICA PHARMACY ADVISORS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ETHICA PHARMACY ADVISORS
ST13
US500000098570962Class
35, 36
Filing
98570962
Registration
8097086
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
01/06/2026
Trademark type
Word
Nice classes
35, 36
Filing date
05/28/2024
Registration date
01/06/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/06/2026
Last transaction
01/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/05/2024
First use in commerce
08/05/2024
Drawing code
4
Owner type
16
Owner location
Madison, WI, US
Examiner
LUEKEN, ABIGAIL JOSEPHINE
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Ethica Pharmacy Advisors, LLC
Representatives
Shane Delsman Godfrey & Kahn, S.C.
Technical classification
Nice Classes
Class 35Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Cost management for the prescription drug benefit plans of others; Pharmaceutical cost management services and drug utilization review services
Class 36
Consulting servicesconducting insurance benefit analysis; Pharmacy benefit management services; Pharmaceutical data analysis for financial purposesformulary and prescription drug coverage and cost data analysis
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/06/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/18/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/18/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/22/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/22/2025
IUAF
USE AMENDMENT FILED
06/03/2025
EISU
TEAS STATEMENT OF USE RECEIVED
06/03/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/25/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/28/2025
PUBO
PUBLISHED FOR OPPOSITION
01/28/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/22/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/08/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
01/08/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/08/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
01/08/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/02/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/10/2024
GNRT
NON-FINAL ACTION E-MAILED
12/10/2024
CNRT
NON-FINAL ACTION WRITTEN
12/10/2024
DOCK
ASSIGNED TO EXAMINER
12/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/04/2024
NWAP
NEW APPLICATION ENTERED
05/28/2024
Continuous trademark protection
Get notified about every new filing that threatens ETHICA PHARMACY ADVISORS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.